Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Cervical Cancer

Free Subscription Articles published in Int J Radiat Oncol Biol Phys Retrieve available abstracts of 137 articles: HTML format

Single Articles

October 2021
1. DAMAST S, Fields E, Kidd E, Harkenrider M, et al
   Reports From Four International Clinical Trials for Cancers of the Cervix, Uterus and Vulva, and a New Guideline for Cervical Cancer.
   Int J Radiat Oncol Biol Phys. 2021;111:299-306.
   PubMed    
   
   
   August 2021
2. KIRCHHEINER K, Smet S, Jurgenliemk-Schulz IM, Haie-Meder C, et al
   Impact of vaginal symptoms and hormonal replacement therapy on sexual outcomes in locally advanced cervical cancer patients after definitive chemoradiotherapy - results from the EMBRACE-I study.
   Int J Radiat Oncol Biol Phys. 2021 Aug 31. pii: S0360-3016(21)02729.
   PubMed     Abstract available
   
   
   June 2021
3. MAHANTSHETTY U, Gurram L, Bushra S, Ghadi Y, et al
   Single application multi-fractionated image guided adaptive High Dose Rate Brachytherapy for Cervical Cancer- Dosimetric & Clinical Outcomes.
   Int J Radiat Oncol Biol Phys. 2021 Jun 16. pii: S0360-3016(21)00732.
   PubMed     Abstract available
   
   
   April 2021
4. STURDZA AE, Poetter R, Kossmeier M, Kirchheiner K, et al
   Nomogram predicting overall survival in locally advanced cervical cancer patients treated by radio-chemotherapy including image guided brachytherapy: a Retro-EMBRACE study.
   Int J Radiat Oncol Biol Phys. 2021 Apr 28. pii: S0360-3016(21)00404.
   PubMed     Abstract available
   
   
   March 2021
5. CHAUDARY N, Hill RP, Stulik L, Milosevic M, et al
   The oral CXCR4 inhibitor X4-136 improves tumor control and reduces toxicity in cervical cancer treated with radiotherapy and concurrent chemotherapy.
   Int J Radiat Oncol Biol Phys. 2021 Mar 23. pii: S0360-3016(21)00291.
   PubMed     Abstract available
   
   
   
6. LI R, Liu Y, Yin R, Yin L, et al
   The Dynamic alternation of Local and Systemic Tumor Immune Microenvironment during Concurrent Chemoradiotherapy of Cervical Cancer: A Prospective Clinical Trial.
   Int J Radiat Oncol Biol Phys. 2021 Mar 10. pii: S0360-3016(21)00243.
   PubMed     Abstract available
   
   
   
7. K JENSEN NB, Potter R, Spampinato S, Fokdal LU, et al
   Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study.
   Int J Radiat Oncol Biol Phys. 2021;109:688-700.
   PubMed     Abstract available
   
   
   February 2021
8. DATTA NR, Stutz E, Gomez S, Bodis S, et al
   In Reply to Roussakow.
   Int J Radiat Oncol Biol Phys. 2021;109:642-644.
   PubMed    
   
   
   
9. ROUSSAKOW S
   In Regard to Datta et al.
   Int J Radiat Oncol Biol Phys. 2021;109:641-642.
   PubMed    
   
   
   December 2020
10. RAUT A, Chopra S, Mittal P, Patil G, et al
    FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2020;108:1248-1256.
    PubMed     Abstract available
    
    
    
11. YUSUFALY T, Miller A, Medina-Palomo A, Williamson CW, et al
    A Multi-atlas Approach for Active Bone Marrow Sparing Radiation Therapy: Implementation in the NRG-GY006 Trial.
    Int J Radiat Oncol Biol Phys. 2020;108:1240-1247.
    PubMed     Abstract available
    
    
    November 2020
12. FEDERICO C, Sun J, Muz B, Alhallak K, et al
    Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side-Effect Profile.
    Int J Radiat Oncol Biol Phys. 2020 Nov 27. pii: S0360-3016(20)34592.
    PubMed     Abstract available
    
    
    
13. BERGER T, Godart J, Jagt T, Vittrup AS, et al
    DOSIMETRIC IMPACT OF INTRA-FRACTION MOTION IN ONLINE-ADAPTIVE IMPT FOR CERVICAL CANCER.
    Int J Radiat Oncol Biol Phys. 2020 Nov 20. pii: S0360-3016(20)34559.
    PubMed     Abstract available
    
    
    
14. ARYA R, Golden DW
    A Curious Case of Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2020;108:846-847.
    PubMed    
    
    
    
15. DYER BA, Mayadev JS
    Restage and Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2020;108:849-850.
    PubMed    
    
    
    
16. SON CH, Hasan Y
    A Parametrial Problem.
    Int J Radiat Oncol Biol Phys. 2020;108:849.
    PubMed    
    
    
    
17. SINGER L, Lee LJ
    50 Gray is Not Enough.
    Int J Radiat Oncol Biol Phys. 2020;108:848-849.
    PubMed    
    
    
    
18. CHINO J, Damast S, Kidd E, Harkenrider M, et al
    Radiation for Cancers of the Uterine Corpus and Cervix: Incremental Steps, and Glimmers of the Future.
    Int J Radiat Oncol Biol Phys. 2020;108:839-845.
    PubMed    
    
    
    
19. RIGAUD B, Anderson BM, Yu ZH, Gobeli M, et al
    Automatic segmentation using deep learning to enable online dose optimization during adaptive radiotherapy of cervical cancer.
    Int J Radiat Oncol Biol Phys. 2020 Nov 9. pii: S0360-3016(20)34484.
    PubMed     Abstract available
    
    
    
20. MAO X, Pineau J, Keyes R, Enger SA, et al
    RapidBrachyDL: Rapid Radiation Dose Calculations in Brachytherapy Via Deep Learning.
    Int J Radiat Oncol Biol Phys. 2020;108:802-812.
    PubMed     Abstract available
    
    
    October 2020
21. HARARI PM, Lambert PF
    Life Beyond COVID: Pay Attention to Viruses.
    Int J Radiat Oncol Biol Phys. 2020;108:348-350.
    PubMed    
    
    
    September 2020
22. DYER BA, Feng CH, Eskander R, Sharabi AB, et al
    Current Status of Clinical Trials for Cervical and Uterine Cancer Using Immunotherapy Combined with Radiation.
    Int J Radiat Oncol Biol Phys. 2020 Sep 14. pii: S0360-3016(20)34287.
    PubMed     Abstract available
    
    
    
23. SMALL W JR, Bosch WR, Harkenrider MM, Strauss JB, et al
    NRG Oncology /RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer- An Update.
    Int J Radiat Oncol Biol Phys. 2020 Sep 6. pii: S0360-3016(20)34220.
    PubMed     Abstract available
    
    
    August 2020
24. VITTRUP AS, Tanderup K, Bentzen SM, Jensen NBK, et al
    Persistence of late substantial patient-reported symptoms (LAPERS) after radiochemotherapy including image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study.
    Int J Radiat Oncol Biol Phys. 2020 Aug 24. pii: S0360-3016(20)34139.
    PubMed     Abstract available
    
    
    July 2020
25. WANG Y, Chen H
    In Reply to Ghadjar et al.
    Int J Radiat Oncol Biol Phys. 2020;107:856.
    PubMed    
    
    
    
26. GHADJAR P, Beck M, Zschaeck S, Wust P, et al
    In Regard to Wang et al.
    Int J Radiat Oncol Biol Phys. 2020;107:855.
    PubMed    
    
    
    April 2020
27. MELL LK, Xu R, Yashar CM, McHale MT, et al
    Phase 1 Trial of Concurrent Gemcitabine and Cisplatin with Image-Guided Intensity Modulated Radiation Therapy for Locoregionally Advanced Cervical Carcinoma.
    Int J Radiat Oncol Biol Phys. 2020 Apr 22. pii: S0360-3016(20)31037.
    PubMed     Abstract available
    
    
    
28. CAPALDI DPI, Hristov DH, Kidd EA
    Parametric Response Mapping of Co-registered Positron Emission Tomography and Dynamic Contrast Enhanced Computed Tomography to Identify Radio-resistant Sub-volumes in Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Apr 3. pii: S0360-3016(20)30951.
    PubMed     Abstract available
    
    
    March 2020
29. ALBUQUERQUE K, Timmerman R
    In Reply to Dalwadi et al.
    Int J Radiat Oncol Biol Phys. 2020;106:889.
    PubMed    
    
    
    
30. DALWADI SM, Bonnen MD, Ludwig MS
    In Regard to Albuquerque et al.
    Int J Radiat Oncol Biol Phys. 2020;106:888-889.
    PubMed    
    
    
    
31. WANG Y, Master WH, Che S, Master YZ, et al
    Outcomes for hyperthermia combined with concurrent radiochemotherapy for patients with cervical cancer.
    Int J Radiat Oncol Biol Phys. 2020 Mar 13. pii: S0360-3016(20)30898.
    PubMed     Abstract available
    
    
    
32. PERDRIZET J, D'Souza D, Skliarenko J, Ang M, et al
    A Cost-Utility Analysis of Magnetic Resonance (MR) Guided Brachytherapy versus Two Dimensional and Computed Tomography (CT) Guided Brachytherapy for Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Mar 10. pii: S0360-3016(20)30895.
    PubMed     Abstract available
    
    
    
33. HASAN Y, Furtado L, Tergas A, Lee N, et al
    A Phase I trial assessing the safety and tolerability of a therapeutic DNA vaccination against HPV16 and HPV18 E6/E7 oncogenes after chemoradiation for cervical cancer.
    Int J Radiat Oncol Biol Phys. 2020 Mar 6. pii: S0360-3016(20)30257.
    PubMed     Abstract available
    
    
    
34. KAMRAVA M, Chino JP, Beriwal S
    SAbR as an Alternative Boost Modality for Cervical Cancer: A Cautionary Exercise.
    Int J Radiat Oncol Biol Phys. 2020;106:472-474.
    PubMed    
    
    
    February 2020
35. RIGAUD B, Cazoulat G, Vedam S, Venkatesan AM, et al
    Modeling Complex Deformations of the Sigmoid Colon Between External Beam Radiation Therapy and Brachytherapy Images of Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Feb 3. pii: S0360-3016(19)34546.
    PubMed     Abstract available
    
    
    
36. KIRCHHEINER K, Potter R, Nout RA, Schwartz-Vittrup A, et al
    Late, Persistent, Substantial, Treatment-Related Symptoms After Radiation Therapy (LAPERS): A New Method for Longitudinal Analysis of Late Morbidity-Applied in the EMBRACE Study.
    Int J Radiat Oncol Biol Phys. 2020;106:300-309.
    PubMed     Abstract available
    
    
    January 2020
37. SERBAN M, Kirisits C, de Leeuw A, Potter R, et al
    Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in Cervical Cancer Brachytherapy: Results From the EMBRACE I Study.
    Int J Radiat Oncol Biol Phys. 2020 Jan 29. pii: S0360-3016(19)34532.
    PubMed     Abstract available
    
    
    
38. MITRA A, Grossman Biegert GW, Delgado AY, Karpinets TV, et al
    Microbial Diversity and Composition is Associated with Patient-Reported Toxicity during Chemo radiation Therapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jan 24. pii: S0360-3016(20)30058.
    PubMed     Abstract available
    
    
    
39. BOURILLON L, Demontoy S, Lenglet A, Zampieri A, et al
    Higher Anti-Tumor Efficacy of the Dual HER3-EGFR Antibody MEHD7945a Combined with Ionizing Irradiation in Cervical Cancer Cells.
    Int J Radiat Oncol Biol Phys. 2020 Jan 17. pii: S0360-3016(19)34537.
    PubMed     Abstract available
    
    
    November 2019
40. LINDEGAARD JC, Petric P, Lindegaard AM, Tanderup K, et al
    Evaluation of a new prognostic tumor score in locally advanced cervical cancer integrating clinical examination and magnetic resonance imaging.
    Int J Radiat Oncol Biol Phys. 2019 Nov 30. pii: S0360-3016(19)34076.
    PubMed     Abstract available
    
    
    
41. ALBUQUERQUE K, Tumati V, Lea J, Ahn C, et al
    A Phase II Trial of Stereotactic Ablative Radiotherapy as a Boost for Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Nov 4. pii: S0360-3016(19)33966.
    PubMed     Abstract available
    
    
    
42. CHOPRA S, Engineer R, Shah S, Shukla R, et al
    MRI and PET Guided Interstitial Brachytherapy for post-surgical vaginal recurrences of cervical cancer: Results of phase II study.
    Int J Radiat Oncol Biol Phys. 2019 Nov 1. pii: S0360-3016(19)33960.
    PubMed     Abstract available
    
    
    June 2019
43. CARPENTER DJ, Jacobs CD, Wong TZ, Craciunescu O, et al
    Changes on mid-chemoradiotherapy FDG-PET/CT for cervical cancer are associated with prognosis.
    Int J Radiat Oncol Biol Phys. 2019 Jun 26. pii: S0360-3016(19)33394.
    PubMed     Abstract available
    
    
    May 2019
44. WAKATSUKI M, Kato S, Ohno T, Banu PA, et al
    Multi-institutional observational study of prophylactic extended-field concurrent chemoradiotherapy using weekly cisplatin for patients with pelvic node-positive cervical cancer in East and Southeast Asia.
    Int J Radiat Oncol Biol Phys. 2019 May 21. pii: S0360-3016(19)30737.
    PubMed     Abstract available
    
    
    April 2019
45. CHINO J, Beriwal S
    Advanced Treatment Technique for Locally Advanced Cervical Cancer: Time for a Standard of Care Shift?
    Int J Radiat Oncol Biol Phys. 2019;103:1098-1099.
    PubMed    
    
    
    
46. LIN AJ, Kidd E, Dehdashti F, Siegel BA, et al
    Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer.
    Int J Radiat Oncol Biol Phys. 2019;103:1088-1097.
    PubMed     Abstract available
    
    
    March 2019
47. TAN LT, Potter R, Sturdza A, Fokdal L, et al
    Change in patterns of failure after image-guided brachytherapy for cervical cancer: analysis from the RetroEMBRACE study.
    Int J Radiat Oncol Biol Phys. 2019 Mar 30. pii: S0360-3016(19)30565.
    PubMed     Abstract available
    
    
    
48. MASON SA, White IM, O'Shea T, McNair HA, et al
    Combined ultrasound and cone beam CT improves target segmentation for image guided radiation therapy in uterine cervix cancer.
    Int J Radiat Oncol Biol Phys. 2019 Mar 11. pii: S0360-3016(19)30316.
    PubMed     Abstract available
    
    
    
49. HAUGE A, Gaustad JV, Huang R, Simonsen TG, et al
    DCE-MRI and Quantitative Histology Reveal Enhanced Vessel Maturation but Impaired Perfusion and Increased Hypoxia in Bevacizumab-Treated Cervical Carcinoma.
    Int J Radiat Oncol Biol Phys. 2019 Mar 8. pii: S0360-3016(19)30315.
    PubMed     Abstract available
    
    
    February 2019
50. OKONOGI N, Wakatsuki M, Kato S, Karasawa K, et al
    A Phase 1/2 Study of Carbon Ion Radiotherapy with Concurrent Chemotherapy for Locally Advanced Uterine Cervical Squamous Cell Carcinoma (Protocol 1302).
    Int J Radiat Oncol Biol Phys. 2019 Feb 27. pii: S0360-3016(19)30286.
    PubMed     Abstract available
    
    
    
51. DATTA NR, Stutz E, Gomez S, Bodis S, et al
    Efficacy and Safety Evaluation of the Various Therapeutic Options in Locally Advanced Cervix Cancer: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials.
    Int J Radiat Oncol Biol Phys. 2019;103:411-437.
    PubMed     Abstract available
    
    
    December 2018
52. HORNE ZD, Karukonda P, Kalash R, Edwards RP, et al
    Single-institution experience in 3D MRI-based brachytherapy for cervical cancer for 239 women: can dose overcome poor response?
    Int J Radiat Oncol Biol Phys. 2018 Dec 31. pii: S0360-3016(18)34224.
    PubMed     Abstract available
    
    
    November 2018
53. FOKDAL L, Tanderup K, Potter R, Sturdza A, et al
    Risk factors for ureteral stricture following radiochemotherapy including image guided adaptive brachytherapy in cervical cancer: results from the XXXXXXX studies.
    Int J Radiat Oncol Biol Phys. 2018 Nov 9. pii: S0360-3016(18)33953.
    PubMed     Abstract available
    
    
    September 2018
54. CHOPRA S, Deodhar K, Pai V, Pant S, et al
    Cancer Stem cells, CD44 and outcomes following chemoradiation in locally advanced cervical cancer: Results from a prospective study.
    Int J Radiat Oncol Biol Phys. 2018 Sep 10. pii: S0360-3016(18)33727.
    PubMed     Abstract available
    
    
    
55. LIN SM, Ku HY, Chang TC, Liu TW, et al
    Outcomes for Cervical Cancer Patients Treated With Radiation in High-Volume and Low-Volume Hospitals.
    Int J Radiat Oncol Biol Phys. 2018;102:184-193.
    PubMed     Abstract available
    
    
    July 2018
56. DORTA-ESTREMERA S, Colbert LE, Mahalakshmi Krishna NS, Yanamandra AV, et al
    Kinetics of intratumoral immune cell activation during chemoradiation for cervical cancer.
    Int J Radiat Oncol Biol Phys. 2018 Jul 12. pii: S0360-3016(18)31409.
    PubMed     Abstract available
    
    
    June 2018
57. SCHERNBERG A, Bockel S, Annede P, Fumagalli I, et al
    Tumor shrinkage during chemoradiation in locally advanced cervical cancer patients: prognostic significance, and impact for image-guided adaptive brachytherapy.
    Int J Radiat Oncol Biol Phys. 2018 Jun 16. pii: S0360-3016(18)30967.
    PubMed     Abstract available
    
    
    
58. LI R, Shinde A, Chen YJ, Amini A, et al
    Survival benefit of adjuvant brachytherapy after hysterectomy with positive surgical margins in cervical cancer.
    Int J Radiat Oncol Biol Phys. 2018 Jun 8. pii: S0360-3016(18)30929.
    PubMed     Abstract available
    
    
    
59. MAHANTSHETTY U, Naga Ch P, Khadanga CR, Gudi S, et al
    A Prospective Comparison of Computed Tomography with Transrectal Ultrasonography Assistance and Magnetic Resonance Imaging-Based Target-Volume Definition During Image Guided Adaptive Brachytherapy for Cervical Cancers.
    Int J Radiat Oncol Biol Phys. 2018 Jun 7. pii: S0360-3016(18)30933.
    PubMed     Abstract available
    
    
    May 2018
60. GROVER S, Bvochora-Nsingo M, Yeager A, Chiyapo S, et al
    Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting.
    Int J Radiat Oncol Biol Phys. 2018;101:201-210.
    PubMed     Abstract available
    
    
    March 2018
61. HAN K, Shek T, Vines D, Driscoll B, et al
    Measurement of Tumor Hypoxia in Patients With Locally Advanced Cervical Cancer Using Positron Emission Tomography with (18)F-Fluoroazomyin Arabinoside.
    Int J Radiat Oncol Biol Phys. 2018 Mar 2. pii: S0360-3016(18)30329.
    PubMed     Abstract available
    
    
    February 2018
62. MANEA E, Escande A, Bockel S, Khettab M, et al
    Risk of Late Urinary Complications Following Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: Refining Bladder Dose-Volume Parameters.
    Int J Radiat Oncol Biol Phys. 2018 Feb 13. pii: S0360-3016(18)30251.
    PubMed     Abstract available
    
    
    
63. KALASH R, Glaser SM, Rangaswamy B, Horne ZD, et al
    Use of Functional Magnetic Resonance Imaging in Cervical Cancer Patients With Incomplete Response on Positron Emission Tomography/Computed Tomography After Image-Based High-Dose-Rate Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2018 Feb 6. pii: S0360-3016(18)30216.
    PubMed     Abstract available
    
    
    December 2017
64. VULPE H, Asamoah FA, Maganti M, Vanderpuye V, et al
    External Beam Radiation Therapy and Brachytherapy for Cervical Cancer: The Experience of the National Centre for Radiotherapy in Accra, Ghana.
    Int J Radiat Oncol Biol Phys. 2017 Dec 21. pii: S0360-3016(17)34493.
    PubMed     Abstract available
    
    
    November 2017
65. LIM-REINDERS S, Keller BM, Al-Ward S, Sahgal A, et al
    Online Adaptive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;99:994-1003.
    PubMed     Abstract available
    
    
    
66. KOK HP, Korshuize-van Straten L, Bakker A, de Kroon-Oldenhof R, et al
    Online Adaptive Hyperthermia Treatment Planning During Locoregional Heating to Suppress Treatment-Limiting Hot Spots.
    Int J Radiat Oncol Biol Phys. 2017;99:1039-1047.
    PubMed     Abstract available
    
    
    
67. MAHANTSHETTY U, Krishnatry R, Hande V, Jamema S, et al
    Magnetic Resonance Image Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: An Experience From a Tertiary Cancer Center in a Low and Middle Income Countries Setting.
    Int J Radiat Oncol Biol Phys. 2017;99:608-617.
    PubMed     Abstract available
    
    
    
68. GLASER S, Mahantshetty U, Lee L, Klopp A, et al
    Genomics and 3-Dimensional Brachytherapy for Cervical Cancer: Significant Steps Forward.
    Int J Radiat Oncol Biol Phys. 2017;99:505-509.
    PubMed    
    
    
    September 2017
69. BAUER-NILSEN K, Hill C, Trifiletti DM, Libby B, et al
    Evaluation of Delivery Costs for External Beam Radiation Therapy and Brachytherapy for Locally Advanced Cervical Cancer Using Time-Driven Activity-Based Costing.
    Int J Radiat Oncol Biol Phys. 2017 Sep 14. pii: S0360-3016(17)33855.
    PubMed     Abstract available
    
    
    
70. FIELDS EC, Melvani R, Hajdok G, D'Souza D, et al
    A Multi-institution, Retrospective Analysis of Cervix Intracavitary Brachytherapy Treatments. Part 1: Is EQD2 Good Enough for Reporting Radiobiological Effects?
    Int J Radiat Oncol Biol Phys. 2017;99:219-226.
    PubMed     Abstract available
    
    
    August 2017
71. JHAWAR S, Hathout L, Elshaikh MA, Beriwal S, et al
    Adjuvant Chemoradiation Therapy for Cervical Cancer and Effect of Timing and Duration on Treatment Outcome.
    Int J Radiat Oncol Biol Phys. 2017;98:1132-1141.
    PubMed     Abstract available
    
    
    
72. KIM TH, Kim MH, Kim BJ, Park SI, et al
    Prognostic Importance of the Site of Recurrence in Patients With Metastatic Recurrent Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:1124-1131.
    PubMed     Abstract available
    
    
    July 2017
73. JOO J, Shin HJ, Park B, Park SY, et al
    Integration Pattern of Human Papillomavirus Is a Strong Prognostic Factor for Disease-Free Survival After Radiation Therapy in Cervical Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2017;98:654-661.
    PubMed     Abstract available
    
    
    April 2017
74. RAMLOV A, Pedersen EM, Rohl L, Worm E, et al
    Risk Factors for Pelvic Insufficiency Fractures in Locally Advanced Cervical Cancer Following Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;97:1032-1039.
    PubMed     Abstract available
    
    
    
75. BINGHAM B, Orton A, Boothe D, Stoddard G, et al
    Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement.
    Int J Radiat Oncol Biol Phys. 2017;97:1040-1050.
    PubMed     Abstract available
    
    
    March 2017
76. NOTICEWALA SS, Li N, Williamson CW, Hoh CK, et al
    Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;97:797-805.
    PubMed     Abstract available
    
    
    
77. MELL LK, Sirak I, Wei L, Tarnawski R, et al
    Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2).
    Int J Radiat Oncol Biol Phys. 2017;97:536-545.
    PubMed     Abstract available
    
    
    January 2017
78. LI N, Carmona R, Sirak I, Kasaova L, et al
    Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical Trials.
    Int J Radiat Oncol Biol Phys. 2017;97:164-172.
    PubMed     Abstract available
    
    
    November 2016
79. HO JC, Allen PK, Bhosale PR, Rauch GM, et al
    Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2016 Nov 17. pii: S0360-3016(16)33438.
    PubMed     Abstract available
    
    
    
80. WILLIAMSON CW, Green G, Noticewala SS, Li N, et al
    Prospective Validation of a High Dimensional Shape Model for Organ Motion in Intact Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96:801-807.
    PubMed     Abstract available
    
    
    
81. SWANICK CW, Castle KO, Vedam S, Munsell MF, et al
    Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96:793-800.
    PubMed     Abstract available
    
    
    October 2016
82. LI N, Noticewala SS, Williamson CW, Shen H, et al
    ATLAS-Based Active Bone Marrow-Sparing Intensity Modulated Radiation Therapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    
    
    
    
83. ARISTOPHANOUS M, Cardenas CE, Ho JC, Lee JS, et al
    Development of a Radiomics-Based Survival Prediction Model for Cervical Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    
    
    
    
84. ONAL C, Guler OC, Akkus Yildirim B
    Prognostic Utility of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiation Therapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    
    
    
    
85. SINGH R, Chopra S, Engineer R, Kannan S, et al
    Impact of Cumulative Radiation Doses to Vagina on Late Toxicity and Sexual Quality of Life in Patients Treated With Postoperative Adjuvant Radiation Therapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    
    
    
    
86. TAKATOSHI T, Uchida N, Tanino T, Sakaguchi H, et al
    Apparent Diffusion Coefficients (ADCs) in Diffusion-Weighted 3.0 Tesla MR Imaging Is Useful in Predicting Therapeutic Response to Concurrent Chemoradiation Therapy in Patients With Uterine Cervical Cancer: A Prospective Study.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    
    
    
    
87. HONG JC, Foote J, Broadwater G, Sosa J, et al
    Total Treatment Duration for Cervical Cancer: Is 55 Days Still the Goal in the Era of Concurrent Chemotherapy?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    
    
    
    
88. HONG JH, Lin SM, Ku HY, Liu TW, et al
    The Influence of Hospital Volume on Disease Outcomes of Advanced Uterine Cervical Cancer Patients: A Nationwide Cohort Study of Taiwan.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    
    
    
    
89. MELL LK, Saenz CC, Yashar CM, McHale MT, et al
    Phase 1 Trial of Bone Marrow Sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin and Gemcitabine in Stage IB-IVA Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    
    
    
    
90. RODIN D, Hanna TP, Burger E, Zubizarreta E, et al
    Global Access to Radiation Therapy for Cervical Cancer: The Cost of Inaction.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    
    
    
    
91. MELL LK, Sirak I, Wei L, Tarnawski RR, et al
    Phase 2 Multicenter Clinical Trial of Bone Marrow-Sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin for Stage IB-IVA Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    
    
    
    
92. NOMDEN C, de Leeuw AA, Tanderup K, Lindegaard JC, et al
    Nodal Failure After Chemoradiation and Magnetic Resonance Imaging Guided Adaptive BT in Cervical Cancer: A Subanalysis Within Embrace.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    
    
    
    
93. XIE L
    Acute Hematologic Toxicity and Long-Term Treatment Outcome of Concurrent Chemoradiation Therapy With Weekly Cisplatin and Paclitaxel in Patients With FIGO Stage IB2-IIIb Intact Cervical Cancer: A Single-Center Phase II Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    
    
    
    
94. XIE C, Jin X, Li L
    Phase 3 Randomized Trial of Comparing Chemoradiation Therapy Versus Radiation Therapy Alone in Lymph Node-Negative Patients With Early-Stage Cervical Cancer Following Radical Hysterectomy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    
    
    
    
95. TSUJII K, Ueda Y, Isono M, Miyazaki M, et al
    Dosimetric Impact of Rotational Setup Errors for Cervical Cancer Patients With Postoperative Volumetric Modulated Arc Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    
    
    
    
96. MELL LK, Sirak I, Wei L, Tarnawski RR, et al
    Longitudinal Assessment of Quality of Life Following Intensity Modulated Radiation Therapy for Cervical Cancer: Preliminary Analysis of the INTERTECC Phase 2 Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    
    
    
    
97. DATTA NR, Rogers S, Hutton B, Klingbiel D, et al
    Network Meta-Analysis in Locally Advanced Cervical Cancer: Evaluation of Outcomes With Chemoradiation Therapy or Thermoradiation Therapy Versus Radiation Therapy Alone.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    
    
    
    
98. FIORENTINO A, Giaj Levra N, Ricchetti F, Fersino S, et al
    Weekly Cisplatin and Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Radical Treatment of Advanced Cervical Cancer in Elderly Patients: Feasibility and Clinical Preliminary Results.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    
    
    
    
99. CHAN KY, Benwell Q, Schneider K, Ang M, et al
    A Canadian Experience: Current State and Challenges of Magnetic Resonance--Guided Cervical Cancer Brachytherapy in Ontario.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    
    
    
    
100. KIM J, Lee J, Lee KJ, Kim Y, et al
     Survival Outcome of Cervical Cancer Patients Staged With Magnetic Resonance Imaging.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
101. GULYBAN A, Baiwir M, Nicolas S, Nguyen PV, et al
     Actual Delivered Dose for CTV and Bladder During External Beam Radiation Therapy of Locally Advanced Cervical Cancer: Deformable Dose Accumulation Quality Assurance and Results.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
102. KIM Y, Liu Y, Flynn RT, Wu X, et al
     Expected Clinical Outcome Improvement of Rotating-Shield Brachytherapy (RSBT) for Cervical Cancer: Tumor Control Probability (TCP) and Normal Tissue Complication Probability (NTCP) Evaluations.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
103. KUO HC, Mehta KJ, Yaparpalvi R, Garg M, et al
     Can Intensity Modulated Proton Therapy (IMPT) Be an Alternative to Image Guided Brachytherapy (IGBT) for Locally Advanced Cervical Cancer?
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
104. RAI B, Miriyala R, Ghoshal S, Ballari NR, et al
     Margins Around the Involved Pelvic Lymph Nodes for Planning Simultaneous Integrated Boost in Patients With Cervical Cancer Undergoing Pelvic Intensity Modulated Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
105. CHEN W, Bai P, Pan J, Zheng X, et al
     To Assess the Changes of Volume and Spatial Location of Target Area During Cone Beam Computed Tomography for Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
106. KAWASHIMA A, Isohashi F, Mabuchi S, Okubo H, et al
     Early Outcomes and Dose-Volume Analysis for Patients With Cervical Cancer Treated With Computed Tomography-Based Treatment Planning in Brachytherapy.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
107. CHENG G, He M, Zhao H, Zhang N, et al
     Radical Hysterectomy With Adjuvant Radiation Therapy Versus Definitive Radiation Therapy for International Federation of Gynecology and Obstetrics Stage IIb Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
108. OGINO I, Kitagawa M, Watanabe S, Aoki S, et al
     Calcium Phosphate Cement Paste Injection as a Marker of Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
109. ISOHASHI F, Mabuchi S, Yoshioka Y, Tamari K, et al
     Postoperative Whole-Pelvic Intensity Modulated Radiation Therapy in Surgically Treated Cervical Cancer Patients With Adverse Risk Factors.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
110. DANG Y, Li X, Liu S, Wei L, et al
     A Retrospective Study of 344 Patients With FIGO Stage IIB Cervical Carcinoma After Neoadjuvant Chemoradiation Therapy in Cervical Cancer: Pelvic Lymph Node Dissection Should Be Tailored.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
111. NOTICEWALA SS, Li N, Williamson CW, Hoh CK, et al
     Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
112. ORWAT K, Mendoza A, Young Pierce J, Cooper SL, et al
     Predictive Value of High-Risk Human Papillomavirus and Positron Emission Tomography/Computed Tomography for Local Control After Chemoradiation for Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
113. KUROKAWA M, Iwai Y, Togasaki G, Kanazawa A, et al
     Postoperative Radiation Therapy for Cervical Cancer: Three-Dimensional Conformal Radiation Therapy (3DCRT) Versus Intensity Modulated Radiation Therapy (IMRT).
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
114. TAGGAR A, Phan T, Traptow L, Banerjee RN, et al
     Cervical Cancer Brachytherapy in Canada: A Focus on Interstitial Brachytherapy Utilization.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
115. SEKII S, Murakami N, Nakamura S, Kashihara T, et al
     Supplementary Bladder Reference Point of High-Dose-Rate Intracavitary Brachytherapy for Cervical Cancer: Feedback 3-Dimension to 2-Dimension.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
116. KHULLAR K, Sudhoff M, Elson JK, Herzog T, et al
     A Comparison of Dosimetric Parameters in PET-Based Active Bone Marrow Volume and Total Bone Volume in Prediction of Hematologic Toxicity in Cervical Cancer Patients Treated with Chemoradiation.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
117. WANG X, Wang P, Li J, Yuan K, et al
     Image Guided Radiation Therapy Boost in Combination With High-Dose-Rate Intracavitary Brachytherapy for the Treatment of Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
118. SHARMA DN, Gandhi AK, Adhikari N
     Definitive Radiation Therapy of Locally Advanced Cervical Cancer Initially Treated With Palliative Hypofractionated Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
119. NEMOTO MW, Ikeda Y, Ii N, Toita T, et al
     Multi-Institutional Comparative Study of MRI Technique in Cervical Cancer Image-Based Brachytherapy (IGBT): 3D MRI With High Sampling Efficiency Versus Conventional 2D Multiplanar MRI.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
120. CHENG JY, Huang EY, Hsu SN, Wang CJ, et al
     Simultaneous Integrated Boost (SIB) of the Parametrium and Cervix in Radiation Therapy for Cervical Cancer: A Dosimetric Study of a New Novel Approach.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
121. SONG Y, Chen X, Erickson BA, Li A, et al
     Improving Delineation of Gross Tumor Volume Using Magnetic Resonance Imaging for External Beam Radiation Therapy of Locally Advanced Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
122. TANAKA H, Kato A, Kawaguchi M, Yamaguchi T, et al
     Pelvic Insufficiency Fractures After Whole-Pelvic Irradiation for Uterine Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
123. LIN SM, Hong JH, Ku HY, Liu TW, et al
     The Prognostic Impact of Overall Treatment Time on Disease Outcomes of Uterine Cervical Cancer Patients: A Nationwide Cohort Study of Taiwan.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
124. BECKTA JM, Wan W, Quinn BA, Fields EC, et al
     Socioeconomic Disparities in Cervical Cancer Patients Presenting to a Tertiary Care Facility.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
125. MAHMOUD OM, Green WR, Gabel M, Gibbon D, et al
     Replicating Landoni's Study in the Era of Chemotherapy: Postoperative or Radical Concurrent Chemoradiation Therapy in Early-Stage Cervical Cancer?
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
126. YUCE SARI S, Guler OC, Gultekin M, Onal C, et al
     Adjuvant Small Pelvic Radiation Therapy in Cervical Cancer Patients With Minor Risk Factors.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
127. AZEVEDO TL, Hess CB, Kamrava M, Tavares Guerreiro Fregnani JH, et al
     Predicting the Necessity of Adding Catheters to Intracavitary Brachytherapy for Women Undergoing Definitive Chemoradiation for Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
128. MANLEY HJ, O'Donnell BP, Echeverria A, Hsieh G, et al
     Treatment Compliance With Radiation for Women treated for Cervical Cancer in a Safety Net Health System.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
129. PAUL AG, Miller SR 2nd, Nalichowski A, Abrams J, et al
     Dosimetric Evaluation of Point A and Volume-Based High-Dose-Rate Plans: A Single-Institution Study on Adaptive Brachytherapy Planning for Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
130. CHIN RI, Tran L, Thomas MA, Siegel B, et al
     Changes in Cervical Cancer FDG Uptake Heterogeneity After Chemoradiation: Association With Tumor Recurrence and Survival.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
131. ZHANG Y, Shi M, Wei LC, Li J, et al
     Safety and Short-Term Effect of Docetaxel and Cisplatin Chemotherapy Concurrent With Pelvic Radiation Therapy in Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
132. SASIDHARAN A, Mahantshetty UM, Engineer R, Chopra S, et al
     Outcome After First Relapse in Patients With Locally Advanced Cervical Cancer Treated With Radical Radio (Chemo) Therapy.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
133. ROBIN TP, Amini A, Behbakht K, Fisher CM, et al
     Brachytherapy Should Not be Omitted When Treating Locally Advanced Neuroendocrine Cervical Cancer with Definitive Chemoradiation Therapy.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
134. MAHMOUD OM, Gabel M, Jhawar S, Gibbon D, et al
     How Important Is Chemotherapy Timing and Treatment Duration in the Adjuvant Management of Cervical Cancer?
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
135. ACHARYA S, Grigsby PW
     Access to Health Care and Disparities in Cervical Cancer Diagnosis, Treatment, and Survival.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
136. WILLIAMSON CW, Green G, Noticewala S, Li N, et al
     Prospective Validation of a High-Dimensional Shape Model for Organ Motion in Intact Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     
     
137. MAHMOUD OM, Gabel M, Gibbon D, Leiser A, et al
     Can Chemotherapy Boost the Survival Benefit of Adjuvant Radiation Therapy in Early-Stage Cervical Cancer With Intermediate Risk Factors: A Population-Based Study.
     Int J Radiat Oncol Biol Phys. 2016;96.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: